Emtricitabine And Tenofovir Disoproxil Fumarate
Generic Name: emtricitabine and tenofovir disoproxil fumarate
Brand Names:
Emtricitabine And Tenofovir Disoproxil Fumarate
Emtricitabine and tenofovir disoproxil fumarate is a fixed-dose combination tablet containing emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) for HIV-1 treatment and pre-exposure prophylaxis.
Overview
Emtricitabine and tenofovir disoproxil fumarate is a fixed-dose combination tablet containing emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) for HIV-1 treatment and pre-exposure prophylaxis.
Uses
Indicated for treating HIV-1 infection in adults and pediatric patients (minimum 17 kg weight) as part of combination therapy, and for pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents (minimum 35 kg weight).
Dosage
Standard dosing is one tablet containing 200 mg FTC and 300 mg TDF once daily orally with or without food.
Side Effects
Most common adverse reactions include diarrhea, nausea, fatigue, headache, dizziness, depression, insomnia, abnormal dreams, and rash.
Interactions
Multiple significant interactions documented with protease inhibitors, hepatitis C antivirals, and nephrotoxic agents.
Warnings
BOXED WARNING: Severe hepatitis B exacerbation risk and drug resistance risks with undiagnosed HIV infection. Includes renal impairment concerns, bone loss, and lactic acidosis warnings. Contraindicated in individuals with unknown or positive HIV-1 status for PrEP use.
Frequently Asked Questions
What is Emtricitabine And Tenofovir Disoproxil Fumarate used for?▼
Indicated for treating HIV-1 infection in adults and pediatric patients (minimum 17 kg weight) as part of combination therapy, and for pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents (minimum 35 kg weight).
What are the side effects of Emtricitabine And Tenofovir Disoproxil Fumarate?▼
Most common adverse reactions include diarrhea, nausea, fatigue, headache, dizziness, depression, insomnia, abnormal dreams, and rash.
What are the important warnings for Emtricitabine And Tenofovir Disoproxil Fumarate?▼
BOXED WARNING: Severe hepatitis B exacerbation risk and drug resistance risks with undiagnosed HIV infection. Includes renal impairment concerns, bone loss, and lactic acidosis warnings. Contraindicated in individuals with unknown or positive HIV-1 status for PrEP use.
Related Medications
Lidicaine
lidicaine
Amide Local Anesthetic [EPC]
Purpose Anesthetic
Eucalyptus Globulus
eucalyptus globulus
Purpose Pediculicide
Tagraxofusp
tagraxofusp
CD123 Interaction [EPC]
11 DESCRIPTION Tagraxofusp-erzs, a CD123-directed cytotoxin, is a fusion protein comprised of a recombinant human interleukin-3 (IL-3) and truncated diphtheria toxin (DT). Tagraxofusp-erzs has an approximate molecular weight of 57,695 Daltons. Tagraxofusp-erzs is constructed by recombinant DNA technology and produced in Escherichia coli cells.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.